Life Sciences
& Healthcare

The life sciences and healthcare industry is growing across Central and Eastern Europe. Indeed, the region is poised to become a major centre of healthcare research and manufacturing in the coming years. Many universities conduct cutting-edge life sciences research and there has been a significant increase in companies manufacturing drugs and other healthcare materials in the region. This creates significant opportunities for companies and investors in the region and beyond.

Our experts advise clients on all phases of their projects, from R&D to manufacturing and sales. We can offer help on a wide range of legal issues, including intellectual property and data protection, compliance and enforcement, litigation, transactions and public procurement. We can also help companies navigate the strict regulations governing the industry and advise them on antitrust and competition issues.


In partnership with US law firm Davis Polk, we advised the pharmaceutical company Affimed Therapeutics during its IPO on NASDAQ, valued at approximately USD 60 million, and its SPO, valued at USD 35 million.

We advised a private company on developing a strategic project for cannabis and cannabinoid treatment, particularly with regard to GDPR compliance and regulatory matters such as the selling of medicinal cannabis online.

We provide ongoing legal services to a private company developing a strategic project in the area of cannabis and cannabinoid treatment. Our services cover corporate law, IP law, and structuring and drafting contracts with universities, non-profit organisations, for-profit organisations, government research institutions and hi-tech companies.

We provide ongoing advice to a pharmaceutical services and drug development company that operates in over 50 countries in connection with agreements for conducting clinical trials. Our work is focused on compliance of the clinical trial setup with Czech and EU regulatory requirements, and on data protection issues.

We are currently advising a pharmaceutical company on the global outsourcing of auxiliary financial transactions and the related transfer of employees to an external service provider.